The Pharmacists' Defence Association (PDA) has created a form to help locum and other pharmacists to report about breach of NHS contract by community pharmacy.
According to the association, they have been told by increasing number of pharmacists about contractors closing pharmacies, despite a locum readily available to
cover the shift.
The PDA said this is an issue of NHS contractual breach and creates difficulties for patients, and so they have created the form to assist members to report
unnecessary closures to the relevant NHS England & Improvement pharmacy contract team.
A locum pharmacist, who does not wish to be named, has alleged that a community pharmacy declined their offer to cover an extra shift for £5 more per hour,
and decided to close the store, denying the public access to services.
The pharmacist recalled the occasion while writing in the PDA's latest member voice article.
Boots pharmacists will receive a pay rise of 4.5 per cent as the pharmacy multiple and PDA Union jointly announce this year's pay settlement.
Following discussions between Boots management services and the PDA Union negotiators, the agreement was reached in relation to this year's pay claim, effective
from 1 November 2022.
The union also announced that those who have already had a pay increase on or since 1 August 2022, where that increase has been less than 4.5 per cent, a 'top up'
increase will be provided, from 1 November 2022, to ensure that all eligible members of the bargaining unit receive a pay increment of not less than 4.5 per cent in
2022.
Boots and the PDA Union have agreed an increase to the pay of those above the maximum market range by 4 per cent with an additional 0.5 per cent non-consolidated
payment.
The Chief Pharmacist for England and Co-Chairs of professional leadership commission has responded to the questions raised by the Pharmacists Defence Association
(PDA)'s member on the professional leadership survey.
In early September, the PDA wrote to the UK's Chief Pharmaceutical Officers to increase transparency and confidence in the process by asking for clarification of
some of the commission's thinking, assumptions, and scope.
On behalf of all four CPhOs, Chief Pharmacist for England David Webb provided feedback: "The Commission has two independent co-chairs and members have agreed to
abide by the 7 principles for the conduct of public life as recommended by the Nolan Commission which form part of the Terms of Reference. Commission members have
been appointed on behalf of all pharmacy professionals to contribute their expertise in and knowledge of professional leadership and are not appointed to represent
their particular countries, organisations, sectors or roles."
The Pharmacists' Defence Association (PDA) is supporting pharmacists in England whose employment has been impacted by the creation of new NHS structures.
As a result of the 2022 Health and Care Act, Integrated Care Systems (ICSs) were established in England, and Clinical Commissioning Groups (CCGs) were closed on 1
July 2022. Each of the ICSs includes two key parts: an Integrated Care Board (ICB) and an Integrated Care Partnership (ICP).
The association said: "The previous structures in England, established by the Health and Social Care Act 2012, originally had over 200 clinical commissioning groups.
This number had reduced over recent years via mergers."
"However, this latest shift to just 42 commissioning entities means a significant change to significantly larger geographies and populations covered by each ICS.
Although each ICS and its activity can be subdivided into 'places', and within places into 'neighbourhoods', it is at the ICS level that the employer is formed."
"Whereas CCGs previously employed many local health professionals, including pharmacists, the new arrangements mean that ICBs are now that employer. The PDA is
supporting members who have contacted its Service Centre about the impact of these changes."
The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist
workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.
Welcoming its publication Alison Jones, PDA Director of Policy said: "It gives greater clarity around the future direction and strategy for professional development,
training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development
of the clinical role of pharmacists to support better patient care.
"However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire
life course.
Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are
regularly highlighted through activities, such as the safer pharmacies survey.
The lessons from Covid crisis applied in the future through collaboration can create a better integration between GP practices, hospitals and community
pharmacies, Pharmacists Defence Association (PDA) has proposed.
Stating that a more integrated healthcare system could enable pharmacists to provide effective and more efficient care to patients, the PDA proposed a model where
at least two pharmacists would be working in each community pharmacy, empowered, and enabled with two-way referral pathways, having more clinical input and full
access to patient records.
"Such an environment could not only help to improve communications between health professionals and increase access to services for patients, but would support
the NHS to operate more effectively."
The Pharmacists' Defence Association (PDA) has issued an advisory information to community pharmacy contractors about Paxlovid antiviral treatment for
non-hospitalised patients.
"Patients will be assessed to see if they meet the criteria for inclusion and will need careful checking to see if Paxlovid therapy is safe due to the significant
number of drug interactions. Assessment and prescribing are provided via dedicated services with dispensing and supply arranged by the central supply service or
via participating community pharmacies," said the PDA.
Every pharmacist can support this service by making themselves familiar with the service set up in their area. This is so that they can provide advice and signpost
to healthcare colleagues and patients.
Pharmacists working in general practice may also be able to help with identifying newly diagnosed highest risk patients. Whilst most of this group should have
already been identified and contacted, no system is entirely foolproof.
The PDA's advisory note provides information around indemnity and links to information about the prescribing and administration of Paxlovid since it is being
provided under a temporary authorisation, and is subject to numerous drug-drug interactions, and is a recommended first-line treatment.
The Pharmacists' Defence Association has reported an increase in the number of pharmacists calling its advice line to inform about the incidences of violence and intimidation from protesters opposing the Covid-19 vaccination programme.
The association noted that such incidents have become more common with protesters "gaining entry to premises in groups and trying to disrupt Covid-19 vaccinations from taking place."
In many cases, pharmacists, staff, and members of the public have been subjected to verbal threats, causing distress and anxiety among those working to deliver the vaccination programme in a safe environment.
The PDA reminded that employers, having a contract with the NHS for the Covid-19 vaccinations, have a duty to keep their staff safe whilst at work.
The General Pharmaceutical Council (GPhC) standards for pharmacy premises also carry a duty to ensure the safety of staff and the public receiving services on those premises.
In response to Thursday (5 January)'s announcement on the proposal of new 'anti-strike' legislation, the Pharmacists Defence Association (PDA) has said that
it will work with other trade unions to defend the fundamental right for workers in the sector to strike.
The association believes that "industrial action should always be a last resort, especially for health professionals such as pharmacists, however having the option
to strike is a fundamental right for working people in a fair and free, civilised society."
"The right to strike is a fundamental right through which employees can act collectively to secure and protect pay and conditions."
It added: "The Trade Union Congress (TUC) are coordinating the challenge to these proposals."
The TUC said in a statement: "The Prime Minister should concentrate on fixing our public services, not attacking public sector staff. The proposed legislation would
make it harder for disputes to be resolved."
The Professional Pharmacists Association (PDA) has demanded efforts to secure greater support and recognition for community pharmacists from governmental
bodies.
In its written evidence provided to the Health and Social Care select committee's pharmacy inquiry, the PDA raised concerns about the well-being of pharmacists,
specifically for those who belong to minority ethnic groups and race and are subjected to bullying, harassment, and ill-treatment.
The association highlighted issues in the workplace that impact pharmacists' health and well-being, including chronic understaffing, sub-standard working
environments, an absence of protected training time, and experiences of racism, violence, and abuse.
Parallel to the PDA's advocacy, the Royal Pharmaceutical Society (RPS) is intensifying calls for prioritising workforce wellbeing within the pharmacy domain.
Stressing the pivotal role of workforce retention in addressing current challenges, RPS emphasises the need for robust support mechanisms and equitable access
to mental health services.
The Pharmacists' Defence Association (PDA) has called on pharmacy employers and pharmacists organisations to make donations towards the Pharmacist Support charity in the new year.
The association has urged them to donate £1 per pharmacist employee or member to the charity group to increase its funding from 2022 onwards.
Pharmacist Support, an independent charity, provides a variety of support services to pharmacists and their families, former pharmacists and pharmacy students in Great Britain.
It provides support through twelve sessions of fully funded counselling topharmacists, students, or trainees.
Since 2018, the association has donated more than £150,000 to the charity, in turn supporting its members who additionally seek assistance from Pharmacist Support.
The Pharmacists' Defence Association (PDA) is playing a vital role in helping pharmacists who are dealing with stress at the workplace. It launched its new
awareness factsheet 'It's Time to Address Stress' last week.
The factsheet looks at the causes and symptoms of stress in the workplace and provides advice on ways pharmacists can access support and improve working conditions.
The association said that it recognises the well-being services offered by employers and specialist charities such as the PDA's charity partner Pharmacist Support
play an important part in helping pharmacists who may be experiencing stress.
However, the PDA is also committed to working with members to challenge employers to provide well workplaces and to help them to make real impact changes. This can
be done by addressing the causes of stress and fulfilling their responsibilities to their employees.
It added: "Under the management of Health and Safety at Work Regulations 1999, employers are required by law to protect employees from harm. Their legal obligations include identifying hazards and risks and implementing ways to reduce or eliminate them. The PDA's new factsheet highlights the importance of employers recognising the hazards causing stress as the health and safety issues they are."
Too many unreasonable demands placed on pharmacists by employers affect their health and wellbeing at work, a stress and wellbeing survey conducted by The Pharmacists' Defence Association (PDA) Union revealed.
The survey, conducted during Autumn 2021, covered views of over 2,000 pharmacists employed by big multiples - Lloyds, Boots, and Well.
This survey used questions developed by the Health and Safety Executive (HSE), which enabled the union to understand more about stress and wellbeing in three of the
largest community pharmacy multiples.
Analysing the survey, the PDA said that some pharmacists working for each of the three employers highlighted "unachievable targets, unrealistic time pressures, and
most worrying of all reported numerous instances of bullying and harassment."
An overwhelming majority of the respondents reflected personal sacrifices made by the pharmacists to ensure patient services are not impacted by the poor conditions
and environments in some pharmacies.
Within the last few weeks, at least six pharmacists have been subjected to interim order applications - either suspended or had significant restrictions
placed upon their registration pending a full 'Fitness to Practise' hearing into serious allegations being made about their prescribing practices, the Pharmacists'
Defence Association (PDA) has found.
It said that there has been a "dramatic increase in action being taken by the pharmacy regulator (GPhC) against pharmacist prescribers associated with certain types
of online prescribing services".
It has warned pharmacist prescribers who work for online pharmacies about the specific risks associated with remote prescribing using a questionnaire-based model,
typically with no direct prescriber/patient interaction.
Common features that underpin the allegations include the following: Overreliance on a patient questionnaire to inform clinical decision making; No patient/prescriber
interaction; Prescribing high risk medicines without adequate safeguards; Inadequate systems and processes leading to inappropriate prescribing; Very high volumes
of prescriptions being authorised in short periods of time; and Prescribers/patient relationship established via an unregulated online portal.
The Pharmacists' Defence Association (PDA) has welcomed the government's defeat in the House of Lords on the Strikes (Minimum Service Levels) Bill.
It believes that the proposed Bill, if enacted, would allow the government to dictate minimum levels of service during times of industrial action, enabling
employers to name specific employees that they require in work.
Those employees could then face losing their jobs if they failed to turn up to work on that day. Trade unions could also be fined if they did not force those named
individuals to go to work.
PDA director, Paul Day said, "This Bill should be of real concern to pharmacists and other health professionals. The idea of their employer being able to effectively
conscript them to work or face the sack does not feel like a positive employment relations environment."
The House of Lords has voted for key amendments to the Bill to prevent unions from being required to force workers to comply. This also prevents workers from being
forced to work or face the sack and allows for greater consultation and Parliamentary scrutiny on the proposals which the Westminster government is trying to
implement.
The House of Commons will now be required to vote on the amendments over the next few weeks. Whilst the House of Lords amendments are likely to be defeated, it
shows the degree of opposition there is to this Bill.
Extending its support for the Prescription Charges Coalition (PCC), the Pharmacists' Defence Association (PDA) is asking pharmacists in England to share their
experiences of patients denying prescriptions due to financial issues.
PDA members who have practiced in the country within the last 12 months are asked to complete the Prescription Charges Coalition survey by Sunday 28 January.
The PCC is an alliance of more than 50 organisations campaigning to abolish unfair prescription charges for people with long-term conditions in England.
All members of the coalition, including PDA and Royal Pharmaceutical Society (RPS), understand that if patients do not receive their prescribed medicines due to the
cost, their health may deteriorate, and this can increase costs for the National Health Service (NHS).
The Pharmacists' Defence Association (PDA) has advised locums that they are under "no direct obligation" to help contractors gather data for an HM Revenue and Customs (HMRC) investigation.
However, they may choose to assist the large contractors "to help ensure HMRC reach a final decision based on all the relevant facts," PDA said.
The HMRC investigation into the tax status of locums forms part of the extension of the IR35 arrangements into the private sector.
The IR35 came into effect from April to ensure that individuals working like employees through their own limited company pay the same income tax as paid by those employed by a company.
In recent weeks, some contractors have contacted locum pharmacists to assist them in data gathering on their work arrangements.
The Pharmacists' Defence Association (PDA) Union has reached a deal for its members working at Boots, covering 6,000 pharmacists employed by the British retailer and pharmacy chain.
As per the agreement, union members working at the multiple will receive a 2 per cent pay rise effective from November 1, 2021, the two entities said in a joint statement.
The settlement, reached under the guidance of Advisory, Conciliation and Arbitration Service (ACAS), covers provisionally registered pharmacists, pharmacists and pharmacist store managers in the bargaining unit for which the PDAU is recognised.
There will be improved benefits for those at the beginning of their careers as "all pharmacists qualifying in 2021 will be paid at least £38k gross FTE, including those who would otherwise be ineligible due to the 1st August cut-off."
LloydsPharmacy has offered three per cent increase in base pay backdated to 1 April for its store pharmacists, the union of Pharmacists' Defence Association
(PDAU) who represented them has announced.
"We are pleased to announce that following a consultation of its members, the PDAU has informed the company that agreement can be reached on the company's latest
offer, made in July 2022," said the PDAU.
The offer made by the company also includes introduction of an overtime rate of 1.5 times basic pay for each hour worked after contracted hours. This will run for
a trial period and be reviewed as part of the next pay round.
"All pharmacists will receive an initial £1,000 payment under the proposed LTIP scheme, paid in April 2024. This will be to all in the bargaining unit and will not
be dependent on meeting any criteria such as targets," said PDAU.
The Pharmacists' Defence Association (PDA) is probing major concerns arising from Boots' communications to pharmacists regarding the company's recently
announced pension arrangements.
In November, Walgreens Boots Alliance (WBA), the parent company of Boots, transferred the Boots employees' pension scheme to the financial service provider Legal
and General (L&G) in a £4.8 billion deal.
Boots notified staff that terms allowing an unreduced pension from age 60 have ceased immediately, following its agreement with L&G.
The PDA highlighted member concerns regarding Boots management's announcement that an unreduced pension from the age of 60 is a discretionary benefit and not
guaranteed under the Boots Pension Scheme (BPS), contrary to some members' assumptions.